Navigation Links
Microfluidics Promotes Scientific University Research Using Nanotechnology with Innovation Incentives

New Academic Research Collaboration (ARC) program makes cutting-edge nanomaterials processing equipment more accessible and valuable

Newton, MA (PRWEB) May 17, 2010 -- Microfluidics (OTCBB: MFLU), the exclusive global provider of Microfluidizer(R) high shear fluid processors, has initiated a formal collaboration program to further promote the use of nanotechnology in scientific research at the university level. Microfluidizer processors are currently used by hundreds of leading academic institutions to develop breakthrough drug delivery technologies and tailor novel applications for the nutraceutical/food, chemical, energy and cosmetic industries.

University researchers who would like to learn more about the program should visit

Microfluidizer technology is unique in its ability to achieve uniform target particle sizes on the nano-level with fully scalable results from lab to production volumes. The Academic Research Collaboration (ARC) program was created to make superior nanomaterials processing methods more accessible to a wider range of academic initiatives while providing further value to facilitate research and development efforts:

  • Purchasing incentive for qualified universities
  • Complimentary annual “Proof of Concept” testing in the Microfluidics Technology Center
  • Extended warranty by one full year
  • Bonus referral program
  • Upgrade/trade-in credits for certain machines and technologies
  • Courtesy “Lunch n' Learn” on-campus seminars
  • Preferred rental arrangements where applicable
  • Beta site, demonstration and publication opportunities

“Partnering with Microfluidics has enabled us to advance exciting new nanotechnology-based methods for drug delivery, for example, to penetrate the blood brain barrier,” said Mansoor Amiji, Ph.D., Distinguished Professor and Chair of Pharmaceutical Sciences at Northeastern University. “This is the only technology successful thus far in creating decorated drug nanoparticles which deliver benefits to specific parts of the body and, therefore, accomplish more with less drug.”

“As you reduce the particle size of your formulation containing the compound of interest, you increase its surface area, thereby improving bioavailability and efficacy and, as a result, reducing adverse side effects by decreasing the required dose for effectiveness,” explained Prof. Robert Nicolosi, Ph.D., of the Department of Clinical Laboratory & Nutritional Sciences at University of Massachusetts Lowell. “Microfluidics provides an enabling technology which has allowed us to develop novel properties for pharmaceutical, nutraceutical and cosmeceutical applications.”

More than one in every ten Microfluidizer processors sold are to universities – a figure Microfluidics expects to increase over time as the core model for biopharmaceutical R&D continues to evolve. The recently launched LV1 low volume processor, which for the first time brings Microfluidizer-quality processing capabilities to samples as small as 1 ml, is an ideal solution for universities with limited or high value raw materials.

“The importance of academic research to the pharmaceutical industry's drug development strategy cannot be understated, and it's increasing every day,” said Michael C. Ferrara, Microfluidics President and CEO. “More big and mid-size pharmas are seeking to collaborate on vital R&D programs with universities equipped with the latest equipment for nanomaterials processing. From oncology drugs and vaccines, to foods enhanced with nutrients and more efficient cathodes for fuel and solar cells, the line between academic research and industry commercialization has been blurred. By bringing our gold standard nanomaterial processors more actively to the university level, we are able to improve our customers' business lines while supporting the crucial growth and innovation indicative of expert professors and graduate students worldwide.”

In addition, existing collaborations with universities have led to revolutions in what is possible using nanotechnology. Continuous manufacturing via crystallization and chemical reactions using bottom-up Microfluidics Reaction Technology(TM) (MRT), for example, was developed in a partnership between Microfluidics CTO Thomai “Mimi” Panagiotou, Ph.D., and Robert Fisher, Ph.D., of the Chemical Engineering Department at the Massachusetts Institute of Technology.

Said Dr. Fisher, “I was intrigued by the opportunity to work closely with Microfluidics to develop improved drug fabrication techniques that enhance delivery and efficacy, which pharmaceutical firms will find extremely compelling. This includes producing suspensions with the smallest possible particle size that have been functionalized for specific targeting.”

More information on the ARC program can be found on or by contacting Kris Sarajian at (+1) 617.969.5454 x233.

Microfluidics International Corporation (OTC Bulletin Board: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.

By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more,

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. New 'Stop Drinking 411' Campaign Promotes Alcohol Recovery and Prevention via Web Social Media
2. New STOP DRINKING 411 Campaign Promotes Alcohol Recovery and Prevention Via Web Social Media
3. AAHFN Promotes Heart Failure Awareness Week Through Webinar
4. UM School of Medicine scientists find new malaria vaccine is safe and promotes immune response in children
5. Father Channels His Grief into Advocacy, Promotes Simple Actions to Make Hospitals Safer for Children
6. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
7. Medical Transcription Services and EHR Provider MxSecure Promotes Tim Erkel to VP, Client Services
8. Hearts and Minds Promotes Wellness; African Americans Living with Mental Illness Have Higher Risk for Other Illnesses.
9. Pinstripe Promotes Jill Schwieters to President of Pinstripe Healthcare
10. Scientific exchange program promotes collaborative quality standards for drugs, food ingredients
11. Scientists find key to gene that promotes cancer metastasis
Post Your Comments:
(Date:11/24/2015)... ALEXANDRIA, VA (PRWEB) , ... November 24, 2015 ... ... encourages people across the United States to support their local poison centers through ... been designated as #GivingTuesday: calls it “a day that inspires people to ...
(Date:11/24/2015)... Marne, MI (PRWEB) , ... November 24, 2015 , ... ... has released a series of recent video interviews with some of the staff members ... life at the residential treatment facility, as well as some of the things that ...
(Date:11/24/2015)... ... ... Aided by seed funding from the Ron Foley Foundation, researchers at Western ... how to detect and treat pancreatic cancer (PC). , WCHN researchers will focus ... (ncRNA), genetic material that is present in the blood of patients with PC. ...
(Date:11/24/2015)... ... November 24, 2015 , ... Abington Hospital – Jefferson ... of Quality® Bariatric Surgery Facility for treating individuals living with morbid or extreme ... services available to its members to help them make informed decisions about their ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Rodney E. Willey , has answered a ... Koala Center for Sleep Disorders, provides treatment for snoring and sleep apnea through ... a Koala Center for Sleep Disorders in the US, one of four in the Illinois ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 --> ... report "Spine Biologics Market by Product Type (Bone Graft, Bine ... Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and ... global market was valued at $1.90 Billion in 2014 and ... CAGR of 4.4% during the forecast period of 2015 to ...
(Date:11/24/2015)... LAUSANNE and BERN, Switzerland ... SA, the ARTORG Center for Biomedical Engineering Research of ... and the Division of Endocrinology, Diabetes and Clinical Nutrition ... announce the start of an exclusive collaboration to develop ... control algorithm for the personalised delivery of insulin for ...
(Date:11/24/2015)... st  Scientific Assembly and Annual Meeting of the Radiological Society ... Chicago on Nov-29 th through Dec-4 ...  Scientific Assembly and Annual Meeting of the Radiological Society of ... Chicago on Nov-29 th through Dec-4 th , ... present its revolutionary whole body CZT digital SPECT/CT solution at the ...
Breaking Medicine Technology: